Irish software startup nabs $25M Series C to speed up clinical trials
The startup's platform is meant to digitize and modernize the still largely manually and paper-based process of running and managing clinical trials.
The startup's platform is meant to digitize and modernize the still largely manually and paper-based process of running and managing clinical trials.
The company's shares were down more than 4 percent in Monday morning trading after the agency's decision, which itself followed a negative AdCom vote in November.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
With some 60 percent of Americans with behavioral issues failing to receive treatment, SilverCloud’s platform can provide life-saving tools towards wellness.
A federal court last year put the kibosh on a deal whereby Allergan transferred to the tribe the Restasis patents, which the tribe then licensed back to Allergan, asserting tribal sovereign immunity to have generic companies' challenge to the patents dismissed.
The drug offers greater convenience and efficacy than the old chemotherapy combination, but its high cost and first impressions among doctors may explain why Jazz had to lower its sales guidance.
The company plans to file a New Drug Application next year. An analyst wrote that it's unclear if the drug will require review by an advisory committee.
Briefing documents from the Psychopharmacologic Drugs Advisory Committee earlier this week had cast doubt on the chances of a positive vote.
The Psychopharmacologic Drugs Advisory Committee will meet on Thursday to vote on whether to recommend the FDA approve the drug, ALKS 5461, an opioid for major depressive disorder.
The selection process whittled the prospective candidate pool down from 700 companies to five finalists tackling healthcare problems ranging from women's health to ophthalmology.
Omar Ishrak highlights a few products with which Medtronic hopes to succeed in value-based care and responds to criticism about how it approaches high-growth companies from an acquisitions.
Gabby Everett, the site director for BioLabs Pegasus Park, offered a tour of the space and shared some examples of why early-stage life science companies should choose North Texas.
Medtronic and SPR Therapeutics are treating chronic pain but while the former has adopted a permanent, implantable neuromodulation treatment, the latter is going the temporary wearable route.
There are now means by which women can receive a medical abortion through online telemedicine. But is this method riskier than a traditional in-person abortion?
Medtronic is rumored to be selling its medical supplies business to Cardinal Health in shift to become a disease management company eager to play a role in the continuum of care as opposed to a widget maker.
B Capital Group led the round but other investors that took part included Other investors include ACT Venture Capital and returning investors, Investec Ventures and AIB Seed Capital Fund, managed by DBIC, NDRC and Enterprise Ireland.
Four companies from the UC-Berkeley side of the CRISPR patent interference case have signed an alliance to recognize each other's rights to the technology. The agreement highlights the potential for many companies to coexist in the expansive CRISPR field.